Equity · Healthcare
UTHR
United Therapeutics Corporation · NasdaqGS
The line runs $567 on 19 May through $535.39 on 17 July, on a scale from $520 to $580. Days the market did not trade hold the previous close, flat.
The chart above plots the price of UTHR over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 41 sessions over that window: $567 on 19 May 2026 through $535.39 on 17 July 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 17, 2026
UTHR insider trades
UTHR has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 16 December 2025.
Showing the 12 most recent of 21 open-market trades in this window. The figures above count all of them.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 21 compensation filings in this window. The figures above count all of them.
UTHR reported financials
UTHR reported revenue of $3.2B for the fiscal year ended 31 Dec 2025. Net income over the same period was $1.3B.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
UTHR earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
UTHR institutional holders
12 of the 45 institutional funds we track reported a UTHR position for the quarter ended 30 Jun 2026 — a combined $1.9B; the latest of those filings landed 14 Aug 2026.
Showing the 10 largest of 12 reported positions. The figures above count all of them.
Source: SEC EDGAR 13F filings
UTHR fails-to-deliver
On 09 Jul 2026, 4,892 shares of UTHR failed to deliver (about $2.7M).
Source: SEC fails-to-deliver (CNS) data